| Net Cash Provided by (Used in) Operating Activities |
$143,956,000 |
USD |
12696% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$95,273,000 |
USD |
-550% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
88,086,000 |
shares |
7.1% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$47,529,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$79,630,000 |
USD |
1.4% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$27,593,000 |
USD |
-0.11% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$6,200,000 |
USD |
-29% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$6,500,000 |
USD |
-25% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$14,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Additional Paid in Capital |
$2,350,075,000 |
USD |
3.8% |
Q3 2025 |
FY 2025 |
| Interest Expense |
$115,845,000 |
USD |
-9.9% |
Q3 2025 |
FY 2025 |